ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,702
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Prompt administration of drotrecogin alfa (activated) is associated with improved survival
Author(s):
AP Wheeler
,
J. Steingrub
,
W Linde-Zwirble
Publication date:
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cardiovascular Innovations and Applications
Data availability:
ScienceOpen disciplines:
Medicine
,
Cardiovascular Medicine
Comments
Comment on this article
Sign in to comment
Similar content
4,702
Cost effectiveness of Drotrecogin alfa (activated) (Xigris™) in severe sepsis
Authors:
DC Angus
,
WT Linde-Zwirble
,
G Clermont
…
Drotrecogin alfa (activated) in severe sepsis patients with 2 or more organ dysfunctions
Authors:
J Dhainaut
,
P. F. Laterre
,
B Basson
…
In patients with severe sepsisrenal dysfunction is predicted by severe protein C deficiency which is improved by drotrecogin alfa (activated) therapy
Authors:
GM Vail
,
D. Wang
,
WL Macias
See all similar
Cited by
1
Treatment of Severe Sepsis: Where Next? Current and Future Treatment Approaches After the Introduction of Drotrecogin Alfa
Authors:
Todd Rice
See all cited by